In this issue
Post-operative endoscopic recurrence on neoterminal ileum in CD
Metabonomics and gut microbiome associated with response to anti-TNF therapy
Laparoscopic ileocaecal resection vs infliximab for terminal ileitis in CD
IBD and risk of COVID-19 infection
Global burden of IBD: 2015 to 2025
Predictors of ustekinumab failure after dose intensification
Rates of surgery for IBD in the era of biologic therapy
Friendships in young people with IBD
Information and support needs of patients living with IBD
Risk of surgery in UC and CD
Science blog: T cell migration and anti-integrins as immune therapies
Please login below to download this issue (PDF)